Last updated on February 2018

A Clinical Trial to Evaluate Safety and Efficacy of a Renal Denervation System in Treatment of Hypertension


Brief description of study

This is a multicentre clinical trial to evaluate safety and efficacy of renal denervation system in treatment of hypertension. Hypertensive patients who meet enrollment criteria will be randomized into treatment group who will receive standardized drugs and renal denervation treatments, or control group who will receive standardized drugs and a sham procedure (renal artery angiography only without denervation). The patients will be monitored for blood pressure changes and any adverse events for 6 months. The safety and efficacy of the device will be evaluated by comparing blood pressure levels and adverse event episodes between the two groups.

Clinical Study Identifier: NCT03261375

Contact Investigators or Research Sites near you

Start Over

Ping Yang, MD

The 3rd Affiliated Hospital Jilin University
Changchun, China
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.